Calcium Channel Blocker Market - Growth, Trends And Forecast (2020 - 2025)
|出版商||Mordor Intelligence LLP||商品編碼||927874|
|出版日期||內容資訊||英文 117 Pages
|鈣拮抗劑的全球市場:成長，趨勢，預測(2020年∼2025年) Calcium Channel Blocker Market - Growth, Trends And Forecast (2020 - 2025)|
|出版日期: 2020年03月01日||內容資訊: 英文 117 Pages||
The Calcium Channel Blocker Market is expected to register a CAGR of 5.1 % during the forecast period. The increasing prevalence rate of cardiovascular diseases and changing lifestyle of people is expected to boost the calcium channel blocker market growth. Hypertension often referred as the elevated blood pressure is one of the major causes associated with heart diseases. According to World Health Organization, approximately 1.13 billion of people globally have hypertension. Furthermore, cardiovascular diseases are one of the leading causes of the death and around 17.9 million people died in 2016 due to it. Calcium antagonist are known to be effective against this indication. Thus, the demand has been steadily growing for this market for better management of the cardiovascular diseases. However, the recent years, also observed some cases related to product recalls which restricts the growth of the studied market.
Dihydropyridines Segment is Expected to Hold a Major Share in the Calcium Channel Blocker Market
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America expected to hold a major market share in the global calcium Channel blocker market due to changing lifestyle among people and increasing prevalence rate of cardiovascular diseases. The adoption of sedentary lifestyle has serious implications on the health of people and are known to cause diseases related to cardiovascular diseases, obesity, high blood pressure, etc. According to the World Health Organization, around 60% - 85% of people, worldwide, have adopted a sedentary life. According to Centre for Disease Control and Prevention, around 31 million adults aged over 50 years lives a sedentary life, and only 1 out of 4 US adults & 1 out 5 school student meets the guideline of physical activity. Heart disease is one of the leading causes of death in U.S., at least one person dies every 37 second due to cardiovascular disease, as reported by Centre for Disease Control and Prevention.
The Calcium Channel Blocker Market is fragmented and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Pfizer Inc, Alvogen, Abbvie Inc, Exela, Pharma Sciences, LLC, Bausch Health Company Inc., GlaxoSmithKline LLC, Silvergate Pharmaceuticals Inc., Novartis AG, Covis Pharma BV, Arbor Pharmaceuticals LLC.